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AbstrACt
Objective A number of promising automated behaviour 
change interventions have been developed using advanced 
phone technology. This paper reviewed the effectiveness 
of interactive voice response (IVR)-based interventions 
designed to promote changes in specific health 
behaviours.
Methods A systematic literature review of papers 
published between January 1990 and September 2017 in 
MEDLINE, CINAHL, Embase, PsycINFO, SCOPUS and the 
Cochrane Central Register of Controlled Trials (CENTRAL) 
was conducted. From the total of 2546 papers identified, 
15 randomised control trials (RCTs) met the eligibility 
criteria and were included in a random effects meta-
analysis. Meta-regression analysis was used to explore 
whether behaviour change techniques (BCTs) that were 
used in the interventions were associated with intervention 
effectiveness.
results Meta-analysis of 15 RCTs showed that IVR-
based interventions had small but significant effects on 
promoting medication adherence (OR=1.527, 95% CI 
1.207 to 1.932, k=9, p=0.000) and physical activity 
(Hedges’ g=0.254, 95% CI 0.068 to 0.439, k=3, p=0.007). 
No effects were found for alcohol (Hedges’ g=−0.077, 
95% CI −0.162 to 0.007, k=4, p=0.073) or diet (Hedges’ 
g=0.130, 95% CI −0.088 to 0.347, k=2, p=0.242). 
In the medication adherence studies, multivariable 
meta-regression including six BCTs explained 100% of 
the observed variance in effect size, but only the BCT 
‘information about health consequences’ was significantly 
associated with effect size (β=0.690, SE=0.199, 95% CI 
0.29 to 1.08, p=0.000).
Conclusion IVR-based interventions appear promising in 
changing specific health behaviours, such as medication 
adherence and physical activity. However, more studies 
are needed to elucidate further the combination of active 
components of IVR interventions that make them effective 
and test their feasibility and effectiveness using robust 
designs and objective outcome measures.
IntrOduCtIOn 
Health-related behaviours have enormous 
impact on some of the leading causes of 
mortality and morbidity.1 2 Evidence show that 
behaviours such as non-adherence to medi-
cations, lack of physical activity, smoking, 
high consumption of alcohol and poor diet 
can cause a number of health conditions.3 
National recommendations suggest that 
health services aiming to prevent and manage 
long-term health conditions should include 
initiatives to change health behaviours. 
Health-related behaviours are highly influ-
enced by people’s environmental context and 
sociocultural circumstances. However, these 
factors may be difficult to alter, at least in the 
short term. Healthcare initiatives to change 
behaviours in individuals or groups might be 
easier to implement and to evaluate.4 
The rapidly evolving field on the use of 
emerging technologies in health interven-
tions and especially in interventions targeting 
behaviour change appears promising5 
because of their potential to reach a large 
number of people and in different contexts. 
The application of such technology in 
primary care can complement the physician’s 
efforts to engage participants in an interven-
tion, especially in a challenging setting, such 
as healthcare in rural and remote areas.6 In 
some cases, such interventions can diminish 
the barriers reported in interventions deliv-
ered face to face such as literacy or the disclo-
sure of personal and sensitive information.
strengths and limitations of this study
 ► This is the first review to examine the effectiveness 
of interactive voice response (IVR) interventions 
designed to promote changes in specific health 
behaviours and to investigate the active ingredients 
associated with intervention effectiveness.
 ► The findings of this review can inform the 
development of future IVR interventions targeting 
specific health behaviours.
 ► Given the small number and low quality of the 
studies included in the meta-analysis, the results 
should be treated with caution.
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Interactive voice response (IVR) is a novel phone-
based platform that can be used to deliver health 
behaviour interventions. The definitions and descrip-
tions of IVR systems vary significantly given the plethora 
of the systems developed for various purposes. A simpli-
fied description of an IVR system is that it is a tele-
phone-based technology that uses touch-tone phones to 
enable the user to interact with the system using the tele-
phone keypad as the interface where the human speaker 
is replaced by high-quality recorded interactive script.7 
In more recent studies, software for voice recognition 
has been applied that might further enhance the accept-
ability8 and the effectiveness of the IVR.9 10 Participants 
can either interact in real time with the IVR system or 
receive and make IVR calls.
This technology offers several advantages, including 
convenience, simplicity and confidentiality.11 One 
of the major benefits is the significant cost savings 
compared to  usual care.12 A number of systematic liter-
ature reviews have documented the incremental effects 
resulting from the use of these technologies in health-
care settings.10 11 13 A recent meta-analysis on telecom-
munication interventions (including IVR) found such 
technologies to be effective in promoting adherence 
to cardiometabolic medications.14 A recent Cochrane 
review on the effectiveness of automated telephone 
communication systems for preventing disease and 
managing long-term conditions concluded that these 
interventions can change patients’ behaviours and 
improve clinical outcomes.15
Although informative, previous reviews described inter-
ventions delivered using different telephone communica-
tion systems (eg, voice messages and short text messages) 
and multiple delivery modes (eg, voice messages and 
access to a healthcare advisor) and included heteroge-
neous outcome measures. These are some of the elements 
that made these interventions complex and the investiga-
tion of their active and effective content challenging. To 
address this gap, the present review aimed to conduct a 
meta-analysis of the effectiveness of IVR interventions on 
different health behaviours and to identify the compo-
nents of these interventions that are associated with their 
effectiveness. The findings could inform the develop-
ment of future IVR interventions. 
The taxonomy of behaviour change techniques (BCTs) 
has been widely used to classify the active intervention 
content that impacts on intervention effectiveness.16 The 
use of specific techniques, either singly or in combina-
tion, have been associated with intervention effectiveness, 
even in people of lower socioeconomic backgrounds.17 
However, little is currently known about which BCTs may 
be associated with the effectiveness of IVR-based interven-
tions. Thus, this review aimed to address this question.
To our knowledge, this is the first attempt to summarise 
the most rigorous evidence on the effectiveness of 
IVR-based interventions to change health behaviours and 
to examine whether and what BCTs are associated with 
intervention effectiveness.
MethOds
search strategy and inclusion and exclusion criteria
Six electronic databases (MEDLINE, CINAHL, Embase, 
PsycINFO, SCOPUS, Cochrane Central Register of 
Controlled Trials (CENTRAL)) were searched for 
studies published in peer-reviewed journals from January 
1990 to September 2017. A detailed search strategy 
was constructed and run with the support of a medical 
librarian, including free text and Medical Subject Head-
ings terms according to availability. Grey literature was not 
searched (see online supplementary file 1, for detailed 
search strategy for each database).
Adults (≥18 years of age) were eligible for inclusion. 
Given the range of descriptions of the IVR delivery mode 
identified through the screening process, we decided to 
adopt a broad definition of IVR interventions and include 
those that consisted of an automated, computer-based 
system, delivering the intervention content through a 
telephone call that facilitated interactive or non-inter-
active voice messages. We included studies that used a 
randomised controlled or cluster randomised controlled 
design to test the effectiveness of such an intervention in 
any setting and that were published in English (online 
supplementary file 2).
We excluded studies when the main content of the 
intervention was delivered using other delivery modes, 
such as text messages, counselling sessions with, or 
follow-up calls from a healthcare provider (eg, please 
see references 18 19), and the impact of the IVR 
content on the intervention effectiveness could not 
be calculated. We also excluded studies that used IVR 
only as a way to collect outcome measures. Similarly, we 
excluded studies that compared the IVR intervention 
with another active type of intervention (eg, tailored 
booklet).
The aim of this review was to identify evidence for the 
effectiveness of IVR-based interventions and inform the 
development of an IVR-based intervention as an adjunct 
to  primary care consultations. Thus, we included 
studies only when they provided evidence about the 
effectiveness of the IVR intervention itself compared to 
usual care or a non-active intervention group.
study selection
Two reviewers independently screened studies by 
title and abstract according to the eligibility criteria. 
Agreement between reviewers at this stage was good 
(kappa=0.6). A third reviewer was available to discuss 
any disagreements. To identify any additional studies 
that fulfilled the inclusion criteria, two reviewers inde-
pendently screened the references of all the eligible 
papers. The three reviewers independently screened 
studies for eligibility at full text. Authors of the eligible 
studies and those of the included studies were contacted 
via email to request missing information. Any disagree-
ments were discussed until consensus was reached 
among the three reviewers. The review protocol was not 
registered.
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data extraction and intervention coding
An extraction form was developed to extract the following 
information: the author, year, sample size, participant 
characteristics, description of the intervention and 
comparator groups, duration and content of the IVR 
intervention, outcome measures and outcome data.
For the alcohol outcome, we extracted the frequency 
and quantity of standard units per extended period of 
time (eg, per week). Alcohol consumption was defined 
as drinking regularly more than 14 units per week. Heavy 
alcohol consumption or binge drinking was defined as 
drinking 4–5 standard units per occasion.20 For the diet 
outcome, we extracted data measuring dietary patterns, 
such as frequency of consumption of recommended 
levels of food (eg, fruits and vegetables ≥5 servings) and 
overall quantity of consumed food (eg, servings of fruit 
and vegetables, per cent of total calories and grams of 
fibre). Unhealthy diet was defined as consuming (a) less 
than five fruits and vegetables per day and/or (b) more 
than 30 g (for men) or 20 g (for women) of saturated fat 
per day, 5 g added sugar per 100 g and 6 g sodium per 
day.21 For the physical activity outcome, we extracted 
the minutes of moderate or greater intensity of physical 
activity. Physical inactivity was defined as taking less than 
(a) 150 min of moderate activity in bouts of 10 min and 
over on at least 5 days a week or (b) 75 min of vigorous 
activity spread across the week or a combination of both 
moderate and vigorous physical activity.22 For the medi-
cation taking outcome, we extracted the percentage 
of tablets taken as prescribed and days of medication 
dispensed to patients. Medication adherence was defined 
as (a) taking at least 80% of the prescribed tablets and/or 
(b) having medications dispensed for at least 95% days of 
a prescribed period.23
We extracted the method to collect each outcome, 
such as self-reported scales (for alcohol, diet, physical 
activity and medication adherence), accelerometers (for 
physical activity) and pill count or electronic pharmacy 
records (for medication adherence). Two reviewers inde-
pendently assessed risk of bias using an adapted version 
of the Cochrane Collaboration tool for assessing risk of 
bias24 (online supplementary file 3).
We coded the BCTs delivered by the IVR delivery mode 
using the Taxonomy V.1.16 We coded the BCTs delivered 
using other delivery modes (eg, letter), only if the content 
of this additional mode informed or was informed by the 
content of the IVR. For example, in Helzer et al6 study,6 the 
BCT ‘feedback on behaviour’ was coded, although deliv-
ered through a bar graph showing the number of drinks, 
because the graph was informed by participants’ reports 
to the IVR system. We coded the intervention content as 
‘personalised’ when it used the participant's name, and as 
‘tailored’ when it delivered different content to different 
participants. We coded one additional technique: ‘report 
whether or not the behaviour was performed’, when 
participants were asked to report (non) performance of 
the behaviour to the IVR system. When there was more 
than one intervention condition and the intervention 
content was different between these conditions (ie, one 
intervention condition included different BCTs from the 
other intervention condition), we included the condition 
that used the greater number of IVR BCTs (eg, Andersson 
2015 25). The three reviewers independently coded the 
BCTs. Any disagreement in BCT coding was discussed 
until agreement was reached between reviewers.
data synthesis and meta-analyses
To calculate the effect size, we used the unadjusted 
values at the end of the intervention for the intervention 
and comparator groups. This was decided based on the 
assumption that measurements at the baseline could have 
a reactive impact on intervention effectiveness,26 27 thus 
to minimise this effect, only follow-up data were included 
in the analysis. For continuous data, we used the means, 
standard deviations (SD) and sample sizes. For dichot-
omous data, we used the number of participants who 
performed the behaviour and the total sample size. Medi-
cation adherence effect sizes are reported as odd ratio 
(OR) and 95% confidence intervals (CIs). Alcohol, diet 
and physical activity effect sizes are reported as Hedges’ 
g and 95% CI.
When more than one intervention group was included 
in a study and the content of these intervention groups 
was similar,6 the outcome data from the intervention 
groups were pooled and compared with the comparator 
group. This was done for Helzer et al6 study, where the 
two intervention groups were similar in terms of content, 
with the only difference being the financial incentives to 
increase compliance to one of the intervention BCTs.
A random effects meta-analysis was conducted for each 
behaviour (alcohol consumption, diet, physical activity 
and medication adherence) to estimate the overall effect 
size. A random effects model was chosen as it allows the 
true effect size to vary across studies.
Assessment of heterogeneity
The degree of heterogeneity was assessed using the I2 
statistic.28 A value of I2 of 25% was considered as indi-
cating low heterogeneity, 50% moderate and 75% high 
heterogeneity.24
Analysis by study size
A subgroup analysis tested whether the study size 
impacted on overall effect size by comparing the effect 
between smaller and larger studies.
Publication bias
The presence of possible publication bias was assessed by 
funnel plot, plotting precision (study-specific standard 
error of the estimate) against the effect size (Hedges’ 
g). Asymmetry in the overall pattern was assessed using 
Egger’s test by regressing the effect size on its standard 
error (SE).29
Meta-regression analyses
In addition, the following meta-regression analyses were 
conducted:
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A. A series of univariable meta-regression analyses, testing 
whether the intervention effect differs if a particular 
BCT was present or absent.
B. A multivariable meta-regression analysis, examining 
which BCTs were associated with the intervention ef-
fect.
The Comprehensive Meta-analysis software was used to 
perform all analyses.30 Statistical significance was set at 
p<0.05.
results
search results
The electronic searches yielded in total 5541 publica-
tions. After duplicate records were removed, title and 
abstract screening was performed on 2546 studies. At 
this stage, papers were excluded if they failed to meet 
the inclusion criteria of RCT study design, usual care or 
no-active comparator group, content and behavioural 
outcome, and use of an IVR delivery mode. In total, 207 
publications were considered relevant for full-text inspec-
tion, of which 156 25 31–43 were included in the meta-anal-
yses (figure 1). The rest of the studies44–50 did not provide 
comparable data to be included in the meta-analysis and 
meta-regression. Included studies targeted changes in 
medication adherence, physical activity, diet and alcohol 
consumption. No study on smoking cessation provided 
sufficient data to be eligible for analysis.
description of the included studies
The majority of the studies targeted changes in a single 
behaviour; eight targeted medication adherence,31–38 
four targeted alcohol  behaviour6 25 39 43 and one targeted 
physical activity.40 Two studies41 42 targeted changes in 
more than one behaviour: one targeted simultaneously 
diet and physical activity41 and the other diet, physical 
Figure 1 PRISMA flow chart of screening process. IVR, interactive voice response; PRISMA, Preferred Reporting Items for 
Systematic Reviews and Meta-Analyses; RCT, randomised controlled trials.
 o
n
 17 June 2019 by guest. Protected by copyright.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2017-018974 on 24 February 2018. Downloaded from 
5Tsoli S, et al. BMJ Open 2018;8:e018974. doi:10.1136/bmjopen-2017-018974
Open Access
activity and medication adherence.42 In total, four investi-
gations in alcohol consumption, two in dietary behaviour, 
three in physical activity and nine in medication adher-
ence were identified.
All of the included studies were RCTs, as no eligible 
cluster RCTs were identified through the screening 
process. The majority of the studies were undertaken in 
the USA,6 31–33 36 37 39–43 two studies in Canada,35 38 one in 
Sweden25 and one study in India.34
The total number of randomised participants was 35 257 
(ranging from 7741 to 14 50233), with a total of 27 867 
completing follow-up measurements. All included trials 
investigated the impact of the intervention in groups of 
adults (range from 17.5/18 to 98 years old) (table 1).
Quality assessment of the included studies
Methodological quality of the included studies widely 
varied. Despite the fact that all the included studies 
used an RCT design, assessment of the randomisation 
process and allocation concealment was challenging for 
the majority of the studies due to lack of information 
provided. Blinding of participants was impossible due to 
the nature of the intervention. Six studies31–33 36 37 41 used 
objective outcome measures for all (medication adher-
ence31–33 36 37) or some of the behavioural outcomes 
(physical activity only).41 Two studies40 42 used objec-
tive outcome measures (ie, accelerometer for physical 
activity) in a subsample of participants to validate self-re-
port measures. On average, fewer than half of the criteria 
were met, resulting in a review with included studies 
having a relatively high risk of bias (table 2).
Characteristics of the delivery mode: intervention group
Several different kinds of IVR systems were used in 
the included studies, and different names were used 
to describe them. The system was described as an IVR 
system in nine studies25 31 33 35–38 41 43 and as an Alcohol 
Therapeutic IVR in one study.39 Other names used were 
automated Telephone Linked Computer system,40 Tele-
phone-Linked Care42 and automated telephone calls.32 34 
The IVR delivery mode was quite variable in structure 
and interaction with the participant. For instance, the 
intervention described by Derose et al32 had few interac-
tive features. Call duration ranged from 40 sec32 to 10 min 
maximum.41 However, only seven studies provided this 
kind of information (table 1).
description of the bCts by behaviour: intervention condition
Alcohol consumption
In interventions targeting alcohol consumption, the most 
frequently coded BCTs were ‘tailored’ and ‘report whether 
or not the behaviour was performed’, all coded in four 
studies; ‘feedback on behaviour’ coded in three studies; 
‘avoidance/reducing exposure to cues for behaviour’, 
‘behaviour substitution’, ‘credible source’, ‘discrepancy 
between current behaviour and goals’, ‘goal setting 
(behaviour)’, ‘personalised’ and ‘social support (unspec-
ified)’, each coded in two studies; ‘distraction’, ‘framing/
reframing’, ‘graded task’, ‘information about health 
consequences’, ‘information about social and environ-
mental consequences’, ‘instructions on how to perform 
the behaviour’, ‘problem solving’, ‘prompts/cues’, pros 
and cons’, ‘reduce negative emotions’, ‘relapse preven-
tion and coping planning’, ‘restructuring the social envi-
ronment’, ‘review behavioural goals’, ‘social comparison’, 
‘social reward’, ‘social support(practical)’ and ‘social 
support (emotional)’, each coded in one study.
Dietary behaviour
In interventions targeting dietary behaviour, the following 
BCTs were coded in each study: ‘tailored’, ‘social support 
(unspecified)’, ‘self-monitoring of outcome(s) of 
behaviour’, ‘prompts/cues’, and ‘action planning’.
Physical activity
In interventions targeting physical activity, the BCTs 
‘tailored’ and ‘self-monitoring of behaviour’ were coded 
in two studies. Each of the BCTs ‘prompts/cues’, ‘action 
planning’, ‘social support (unspecified)’, ‘problem 
solving’ and ‘reporting whether or not the behaviour was 
performed’ were coded in one study.
Medication adherence
In interventions targeting medication adherence, the 
BCT ‘social support (unspecified)’ was coded in eight 
studies; ‘prompts/cues’ in five studies; 'tailored' and 
‘information about health consequences’ each coded in 
four studies; ‘personalised’ and ‘report whether or not the 
behaviour was performed’, each coded in three studies; 
‘social reward’ was coded in two studies; and ‘feedback 
on behaviour’ and ‘problem solving’ each coded in one 
study
Characteristics of the delivery mode and content: comparator 
condition
Most studies did not provide a detailed description of 
the comparator condition. The comparator condition 
was most commonly described as ‘usual care’ but without 
specifying the content and, in some cases, the delivery 
mode of this care. One study34 mentioned that the usual 
care consisted of three counselling sessions, laboratory 
and clinical tests. The comparator condition consisted of 
a health education class on non-physical activity topics in 
one study,40 a diabetes prevention class in another study41 
and one IVR call with general advice on health and a 
guide via email in another study.36 36No BCTs delivered 
via IVR were coded in the comparator condition.
Meta-analyses
The meta-analysis of included studies demonstrated 
that IVR-based interventions had a small but statistically 
significant effect on increasing physical activity (Hedges’ 
g=0.254, 95% CI 0.068 to 0.439, k=3, p=0.007) and medi-
cation adherence (OR=1.527, 95% CI 1.207 to 1.932, 
k=9, p=0.000). There was no statistically significant effect 
on behaviours related to diet (Hedges’ g=0.130, 95% CI 
−0.088 to 0.347, k=2, p=0.242) or alcohol consumption 
 o
n
 17 June 2019 by guest. Protected by copyright.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2017-018974 on 24 February 2018. Downloaded from 
6 Tsoli S, et al. BMJ Open 2018;8:e018974. doi:10.1136/bmjopen-2017-018974
Open Access 
Ta
b
le
 1
 
S
um
m
ar
y 
of
 s
tu
d
y 
ch
ar
ac
te
ris
tic
s
A
ut
ho
r(
s)
S
et
ti
ng
 a
nd
 
co
un
tr
y
S
am
p
le
 c
ha
ra
ct
er
is
ti
cs
 a
t 
ra
nd
o
m
is
at
io
n
(s
am
p
le
 s
iz
e,
 g
en
d
er
 a
nd
 
ag
e)
B
eh
av
io
ur
In
te
rv
en
ti
o
n 
ch
ar
ac
te
ri
st
ic
s
D
ur
at
io
n
O
ut
co
m
e 
m
ea
su
re
m
en
ts
A
nd
er
ss
on
,2
5
U
ni
ve
rs
ity
, 
S
w
ed
en
n=
70
8
I: 
n=
33
4
C
: n
=
37
4
M
/F
>
17
.5
/1
8 
ye
ar
s 
ol
d
A
lc
oh
ol
 
co
ns
um
p
tio
n
In
te
rv
en
tio
n:
to
ta
l I
V
R
: 4
 IV
R
 o
ut
b
ou
nd
 c
al
ls
 
b
et
w
ee
n 
13
:0
0 
an
d
 1
9:
00
 o
n 
a 
M
on
d
ay
 a
nd
 T
ue
sd
ay
. E
ac
h 
vo
ic
e 
m
es
sa
ge
 in
vo
lv
ed
 le
ss
 
th
an
 5
00
 w
or
d
s
C
om
p
ar
at
or
: n
o 
IV
R
 c
al
ls
.
Fo
llo
w
-u
p
 a
ss
es
sm
en
t:
 
6 
w
ee
ks
D
ur
at
io
n 
of
 t
he
 IV
R
 
in
te
rv
en
tio
n:
 2
 w
ee
ks
*A
lc
oh
ol
 U
se
 D
is
or
d
er
s 
Id
en
tifi
ca
tio
n 
Te
st
, a
nd
 
16
-i
te
m
 D
ai
ly
 D
rin
ki
ng
 
Q
ue
st
io
nn
ai
re
C
iz
m
ic
 e
t 
al
,3
1
K
ai
se
r 
P
er
m
an
en
te
, 
U
S
A
n=
24
6
I: 
n=
12
7
C
: n
=
11
9
≥1
8 
ye
ar
s 
ol
d
M
ed
ic
at
io
n 
ad
he
re
nc
e 
fo
r 
os
te
op
or
os
is
 (o
ra
l 
b
is
p
ho
sp
ho
na
te
)
In
te
rv
en
tio
n:
 1
 o
ut
b
ou
nd
 IV
R
 
ca
ll 
of
 a
ve
ra
ge
 d
ur
at
io
n 
of
 1
45
–
10
9 
se
co
nd
s.
 A
 le
tt
er
 w
as
 s
en
t 
7 
d
ay
s 
af
te
r 
th
e 
ca
ll 
to
 t
ho
se
 
p
at
ie
nt
s 
w
ho
 h
ad
 n
ot
 r
efi
lle
d
 
th
ei
r 
m
ed
ic
at
io
ns
.
C
om
p
ar
at
or
: n
o 
ca
lls
.
Fo
llo
w
-u
p
 a
ss
es
sm
en
t:
 
25
 d
ay
s 
af
te
r 
en
ro
lm
en
t 
an
d
 a
t 
6 
m
on
th
s 
fo
r 
th
os
e 
no
t 
m
ee
tin
g 
th
e 
25
 o
ut
co
m
e
D
ur
at
io
n 
of
 t
he
 IV
R
 
in
te
rv
en
tio
n:
 1
 c
al
l o
n 
th
e 
d
ay
 o
f e
nr
ol
m
en
t
M
ed
ic
at
io
n 
P
os
se
ss
io
n 
R
at
io
D
er
os
e 
et
 a
l,3
2
K
ai
se
r 
P
er
m
an
en
te
, 
U
S
A
n=
52
16
I: 
n=
26
06
C
: n
=
26
10
M
/F
>
18
 y
ea
rs
 o
ld
M
ed
ic
at
io
n 
ad
he
re
nc
e 
fo
r 
C
V
D
s 
(s
ta
tin
s)
In
te
rv
en
tio
n:
 o
ut
b
ou
nd
 c
al
l, 
1–
2  
w
ee
ks
 a
ft
er
 t
he
 p
re
sc
rip
tio
n 
d
at
e,
 le
tt
er
s 
w
er
e 
se
nt
 1
 w
ee
k 
af
te
r 
th
e 
ca
ll 
to
 t
ho
se
 p
at
ie
nt
s 
w
ho
 h
ad
 n
ot
 r
efi
lle
d
 t
he
ir 
m
ed
ic
at
io
ns
.
C
om
p
ar
at
or
: n
o 
ca
lls
 o
r 
le
tt
er
.
Fo
llo
w
-u
p
 a
ss
es
sm
en
t:
 
25
 d
ay
s 
fr
om
 
ra
nd
om
is
at
io
n 
an
d
 
in
iti
at
io
n 
of
 t
el
ep
ho
ne
 
ca
lls
D
ur
at
io
n 
of
 t
he
 IV
R
 
in
te
rv
en
tio
n:
 a
p
p
ro
x.
1 
w
ee
k
N
um
b
er
 o
f d
is
p
en
sa
tio
n 
at
 t
hr
ee
 in
te
rv
al
s 
in
 t
he
 
fo
llo
w
in
g 
to
 r
an
d
om
is
at
io
n 
ye
ar
, c
ol
le
ct
ed
 b
y 
el
ec
tr
on
ic
 p
ha
rm
ac
y 
re
co
rd
s.
E
st
ab
ro
ok
s 
41
K
ai
se
r 
P
er
m
an
en
te
, 
U
S
A
n=
77
I: 
n=
39
C
: n
=
38
M
/F
>
18
 y
ea
rs
 o
ld
P
hy
si
ca
l a
ct
iv
ity
, 
d
ie
t
In
te
rv
en
tio
n:
 1
ou
tb
ou
nd
 IV
R
 
ca
ll 
p
er
 w
ee
k.
 E
ac
h 
ca
ll 
la
st
ed
 
5–
10
 m
in
 a
nd
 t
ar
ge
te
d
 p
hy
si
ca
l 
ac
tiv
ity
 o
r 
d
ie
t
C
om
p
ar
at
or
: n
o 
ca
lls
.
Fo
llo
w
-u
p
 a
ss
es
sm
en
t:
 
3  
m
on
th
s
D
ur
at
io
n 
of
 t
he
 IV
R
 
in
te
rv
en
tio
n:
 3
 m
on
th
s
P
hy
si
ca
l a
ct
iv
ity
: 
*A
ct
ig
ra
p
h 
ac
ce
le
ro
m
et
er
 
fo
r 
p
hy
si
ca
l a
ct
iv
ity
 
(m
od
er
at
e 
an
d
 v
ig
or
ou
s)
 
an
d
 r
ap
id
 a
ss
es
sm
en
t 
p
hy
si
ca
l a
ct
iv
ity
 s
ca
le
.
D
ie
t:
 q
ue
st
io
nn
ai
re
 fo
r 
d
ie
ta
ry
 h
ab
its
 (s
ta
rt
in
g 
th
e 
co
nv
er
sa
tio
n 
q
ue
st
io
nn
ai
re
)
C
on
tin
ue
d
 o
n
 17 June 2019 by guest. Protected by copyright.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2017-018974 on 24 February 2018. Downloaded from 
7Tsoli S, et al. BMJ Open 2018;8:e018974. doi:10.1136/bmjopen-2017-018974
Open Access
A
ut
ho
r(
s)
S
et
ti
ng
 a
nd
 
co
un
tr
y
S
am
p
le
 c
ha
ra
ct
er
is
ti
cs
 a
t 
ra
nd
o
m
is
at
io
n
(s
am
p
le
 s
iz
e,
 g
en
d
er
 a
nd
 
ag
e)
B
eh
av
io
ur
In
te
rv
en
ti
o
n 
ch
ar
ac
te
ri
st
ic
s
D
ur
at
io
n
O
ut
co
m
e 
m
ea
su
re
m
en
ts
H
el
ze
r 
et
 a
l,6
P
rim
ar
y 
ca
re
 
cl
in
ic
s,
U
S
A
n=
34
8
I: 
n=
15
6
C
: n
=
92
M
/F
>
21
 y
ea
rs
 o
ld
A
lc
oh
ol
 
co
ns
um
p
tio
n
In
te
rv
en
tio
n:
 p
ar
tic
ip
an
ts
 m
ad
e 
th
e 
ca
lls
 t
o 
th
e 
IV
R
 s
ys
te
m
 d
ai
ly
 
(in
b
ou
nd
 c
al
ls
). 
Th
e 
d
ur
at
io
n 
of
 e
ac
h 
ca
ll 
d
ec
re
as
ed
 t
he
 fi
rs
t 
m
on
th
 o
f c
al
lin
g,
 r
ea
ch
in
g 
a 
m
ea
n 
of
 a
p
p
ro
xi
m
at
el
y 
2 
m
in
C
om
p
ar
at
or
: n
o 
ca
lls
 t
o 
th
e 
IV
R
 
sy
st
em
Fo
llo
w
-u
p
 a
ss
es
sm
en
t:
 
6 
m
on
th
s
D
ur
at
io
n 
of
 t
he
 IV
R
 
in
te
rv
en
tio
n:
 6
 m
on
th
s
*T
he
 T
im
el
in
e 
Fo
llo
w
 B
ac
k 
(T
LF
B
) t
oo
l 
K
in
g 
et
 a
l,4
0
C
om
m
un
ity
 
le
ve
l, 
U
S
A
n=
14
5
I: 
n=
75
C
: n
=
70
M
/F
≥5
5 
ye
ar
s 
ol
d
P
hy
si
ca
l a
ct
iv
ity
In
te
rv
en
tio
n:
15
 o
ut
b
ou
nd
 c
al
ls
 fo
r 
th
e 
d
ur
at
io
n 
of
 t
he
 in
te
rv
en
tio
n.
C
om
p
ar
at
or
: h
ea
lth
 e
d
uc
at
io
n 
cl
as
se
s.
Fo
llo
w
-u
p
 a
ss
es
sm
en
t 
at
 6
 m
on
th
s
D
ur
at
io
n 
of
 t
he
 IV
R
 
in
te
rv
en
tio
n:
 1
2 
m
on
th
s
*S
ta
nf
or
d
 7
 d
ay
 p
hy
si
ca
l 
ac
tiv
ity
 r
ec
al
l, 
an
d
 
C
om
m
un
ity
 H
ea
lth
y 
A
ct
iv
iti
es
 M
od
el
 P
ro
gr
am
 
fo
r 
S
en
io
rs
 q
ue
st
io
nn
ai
re
, 
an
d
 a
cc
el
er
om
et
er
 fo
r 
m
ax
 7
 d
ay
s 
fo
r 
26
%
 o
f 
st
ud
y 
ra
nd
om
ly
 s
el
ec
te
d
 
p
ar
tic
ip
an
ts
.
M
ig
ne
au
lt 
et
 a
l,4
2
H
os
p
ita
l a
nd
 
co
m
m
un
ity
 
he
al
th
 
ce
nt
re
s,
 U
S
A
n=
33
7
I: 
n=
16
9
C
: n
=
16
8
M
/F
≥3
5  
ye
ar
s 
ol
d
P
hy
si
ca
l a
ct
iv
ity
D
ie
t
M
ed
ic
at
io
n 
ad
he
re
nc
e 
fo
r 
C
V
D
s 
(a
nt
ih
yp
er
te
ns
iv
e)
In
te
rv
en
tio
n:
 1
ou
tb
ou
nd
 c
al
l p
er
 
w
ee
k 
fo
r 
32
 w
ee
ks
. F
ro
m
 t
ho
se
 
12
 c
al
ls
 in
cl
ud
ed
 m
es
sa
ge
s 
fo
r 
p
hy
si
ca
l a
ct
iv
ity
; 9
 c
al
ls
 in
cl
ud
ed
 
m
es
sa
ge
s 
fo
r 
d
ie
t 
co
ns
um
p
tio
n 
an
d
 8
 c
al
l i
nc
lu
d
ed
 m
es
sa
ge
s 
fo
r 
m
ed
ic
at
io
n 
ad
he
re
nc
e.
C
om
p
ar
at
or
: u
su
al
 p
rim
ar
y 
ca
re
.
Fo
llo
w
-u
p
 a
ss
es
sm
en
t:
 
8  
m
on
th
s
D
ur
at
io
n 
of
 t
he
 IV
R
 
in
te
rv
en
tio
n:
 8
 m
on
th
s
P
hy
si
ca
l a
ct
iv
ity
: 
*S
tr
uc
tu
re
d
 in
te
rv
ie
w
 
7  
D
ay
 P
A
R
 (s
ub
sc
al
e 
m
in
ut
es
 p
er
 w
ee
k)
, a
nd
 
ac
ce
le
ro
m
et
er
 fo
r 
m
ax
 
7  
d
ay
s 
(fo
r 
48
 r
an
d
om
ly
 
se
le
ct
ed
 p
ar
tic
ip
an
ts
).
D
ie
t:
 P
ic
tu
r e
-s
or
t 
Fo
od
 
Fr
eq
ue
nc
y 
Q
ue
st
io
nn
ai
re
M
ed
ic
at
io
n 
ad
he
re
nc
e:
 
M
or
is
ky
 M
ed
ic
at
io
n 
A
d
he
re
nc
e 
S
ca
le
R
os
e 
et
 a
l,3
9
C
om
m
un
ity
, 
U
S
A
n=
15
8
I: 
n=
81
C
: n
=
77
M
/F
≥1
8  
ye
ar
s 
ol
d
A
lc
oh
ol
 
co
ns
um
p
tio
n
In
te
rv
en
tio
n:
 d
ai
ly
 o
ut
b
ou
nd
 
ca
lls
, w
ith
 s
ub
se
q
ue
nt
 in
b
ou
nd
 
ca
lls
.
C
om
p
ar
at
or
: u
su
al
 c
ar
e.
Fo
llo
w
-u
p
 a
ss
es
sm
en
t:
 
4  
m
on
th
s
D
ur
at
io
n 
of
 t
he
 IV
R
 
in
te
rv
en
tio
n:
 4
 m
on
th
s
TL
FB
 t
oo
l (
d
rin
ks
 p
er
 
w
ee
k)
.
Ta
b
le
 1
 
C
on
tin
ue
d
 
C
on
tin
ue
d
 o
n
 17 June 2019 by guest. Protected by copyright.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2017-018974 on 24 February 2018. Downloaded from 
8 Tsoli S, et al. BMJ Open 2018;8:e018974. doi:10.1136/bmjopen-2017-018974
Open Access 
A
ut
ho
r(
s)
S
et
ti
ng
 a
nd
 
co
un
tr
y
S
am
p
le
 c
ha
ra
ct
er
is
ti
cs
 a
t 
ra
nd
o
m
is
at
io
n
(s
am
p
le
 s
iz
e,
 g
en
d
er
 a
nd
 
ag
e)
B
eh
av
io
ur
In
te
rv
en
ti
o
n 
ch
ar
ac
te
ri
st
ic
s
D
ur
at
io
n
O
ut
co
m
e 
m
ea
su
re
m
en
ts
R
os
e 
et
 a
l,4
3
P
rim
ar
y 
ca
re
, 
U
S
A
n=
18
55
I: 
93
8
C
: 9
17
M
/F
≥1
8 
ye
ar
s 
ol
d
A
lc
oh
ol
 
co
ns
um
p
tio
n
In
te
rv
en
tio
n:
 s
in
gl
e 
IV
R
 c
al
l
C
om
p
ar
at
or
: u
su
al
 c
ar
e.
Fo
llo
w
-u
p
 a
ss
es
sm
en
t:
 
en
d
 o
f i
nt
er
ve
nt
io
n.
 
D
ur
at
io
n 
of
 t
he
 IV
R
 
in
te
rv
en
tio
n:
 U
nc
l
TL
FB
 t
oo
l (
d
rin
ks
 p
er
 
w
ee
k)
.
S
he
rr
ar
d
 e
t 
al
,3
8
U
ni
ve
rs
ity
 o
f 
O
tt
aw
a 
H
ea
rt
 
In
st
itu
te
 
(U
O
H
I),
 
C
an
ad
a
n=
33
1
M
/F
>
18
 y
ea
rs
 o
ld
M
ed
ic
at
io
n 
ad
he
re
nc
e 
fo
r 
C
V
D
s 
(d
is
ch
ar
ge
d
 
p
os
ts
ur
ge
ry
 
m
ed
ic
at
io
ns
) 
In
te
rv
en
tio
n:
 1
1 
ou
tb
ou
nd
 IV
R
 
ca
ll 
in
 p
re
d
et
er
m
in
ed
 t
im
e 
fo
r 
th
e 
d
ur
at
io
n 
of
 t
he
 in
te
rv
en
tio
n
C
om
p
ar
at
or
: u
su
al
 m
ed
ic
al
 c
ar
e.
Fo
llo
w
-u
p
 a
ss
es
sm
en
t:
 
6 
m
on
th
s
D
ur
at
io
n 
of
 t
he
 IV
R
 
in
te
rv
en
tio
n:
 6
 m
on
th
s
S
el
f-
re
p
or
te
d
 (s
in
gl
e 
ite
m
: r
em
ai
ne
d
 o
r 
no
t 
on
 
m
ed
ic
at
io
n)
S
he
rr
ar
d
 e
t 
al
,3
5
H
os
p
ita
l 
in
 O
nt
ar
io
, 
C
an
ad
a
n=
16
08
I: 
n=
80
3
C
: n
=
80
5
M
/F
>
18
 y
ea
rs
 o
ld
M
ed
ic
at
io
n 
ad
he
re
nc
e 
fo
r 
co
ro
na
ry
 
sy
nd
ro
m
e
In
te
rv
en
tio
n:
 5
 o
ut
b
ou
nd
 IV
R
 
ca
lls
 in
 p
re
d
et
er
m
in
ed
 t
im
e 
b
et
w
ee
n 
10
:0
0 
an
d
 1
2:
00
, 
15
:0
0–
17
:0
0 
or
 1
8:
00
–2
0:
00
, f
or
 
th
e 
d
ur
at
io
n 
of
 t
he
 in
te
rv
en
tio
n.
C
om
p
ar
at
or
: u
su
al
 m
ed
ic
al
 c
ar
e.
Fo
llo
w
-u
p
 a
ss
es
sm
en
t:
 
12
 m
on
th
s
D
ur
at
io
n 
of
 t
he
 
in
te
rv
en
tio
n:
 1
2 
m
on
th
s
S
el
f-
re
p
or
te
d
 (s
in
gl
e 
ite
m
: r
em
ai
ne
d
 o
r 
no
t 
on
 
m
ed
ic
at
io
n)
.
S
he
t 
et
 a
l,3
4
Tw
o 
am
b
ul
at
or
y 
cl
in
ic
s 
an
d
 
on
e 
p
riv
at
e 
H
IV
 c
lin
ic
, 
In
d
ia
n=
63
1
I: 
n=
31
5
C
: n
=
31
6
M
/F
18
–6
0  
ye
ar
s 
ol
d
M
ed
ic
at
io
n 
ad
he
re
nc
e 
fo
r 
H
IV
 
(A
R
T)
In
te
rv
en
tio
n:
 1
ou
tb
ou
nd
 a
nd
 
in
te
ra
ct
iv
e 
IV
R
 c
al
l p
er
 w
ee
k 
in
 
p
re
d
et
er
m
in
ed
 t
im
e 
an
d
 w
ee
kl
y 
no
n-
in
te
ra
ct
iv
e 
ca
lls
 4
 d
ay
s 
af
te
r 
th
e 
IV
R
 c
al
l
C
om
p
ar
at
or
: u
su
al
 m
ed
ic
al
 c
ar
e.
Fo
llo
w
-u
p
 a
ss
es
sm
en
t:
 
24
 m
on
th
s
D
ur
at
io
n 
of
 t
he
 
in
te
rv
en
tio
n:
 U
nc
l
P
ill
 c
ou
nt
 m
ea
su
re
d
 b
y 
re
se
ar
ch
er
.
S
ta
cy
 e
t 
al
,3
6
La
rg
e 
he
al
th
 
b
en
efi
ts
 
co
m
p
an
y,
 
U
S
A
n=
57
8
M
/F
≥2
1  
ye
ar
s 
ol
d
M
ed
ic
at
io
n 
ad
he
re
nc
e 
fo
r 
C
V
D
s 
(s
ta
tin
s)
In
te
rv
en
tio
n:
 3
ou
tb
ou
nd
 IV
R
 
ca
lls
C
om
p
ar
at
or
: 1
 IV
R
 c
al
l w
ith
 
ge
ne
ra
l h
ea
lth
 a
d
vi
ce
.
Fo
llo
w
-u
p
 a
ss
es
sm
en
t:
 
6  
m
on
th
s
D
ur
at
io
n 
of
 t
he
 
in
te
rv
en
tio
n:
 U
nc
l
P
oi
nt
 p
re
va
le
nc
e 
ad
he
re
nc
e 
co
lle
ct
ed
 
b
y 
el
ec
tr
on
ic
 m
ed
ic
al
 
re
co
rd
s.
Vo
llm
er
 e
t 
al
,3
7
K
ai
se
r 
P
er
m
an
en
te
, 
U
S
A
n=
85
17
M
/F
18
–9
8  
ye
ar
s 
ol
d
M
ed
ic
at
io
n 
ad
he
re
nc
e 
fo
r 
as
th
m
a 
(IC
S
)
In
te
rv
en
tio
n:
 e
ac
h 
p
ar
tic
ip
an
t 
re
ce
iv
ed
 1
 o
f t
he
 3
 o
ut
b
ou
nd
 
IV
R
 c
al
l t
yp
es
, e
ac
h 
ca
ll 
la
st
ed
 
2–
3  
m
in
ut
es
1.
 R
efi
ll 
re
m
in
d
er
: l
as
t 
IC
S
 
d
is
p
en
si
ng
 >
1  
m
on
th
 a
nd
 <
30
 
d
ay
s 
su
p
p
ly
2.
 T
ar
d
y 
re
fil
l: 
>
1 
m
on
th
 p
as
t 
p
r o
je
ct
ed
 r
efi
ll 
d
at
e
3.
 In
iti
at
or
/r
es
ta
rt
: s
ta
rt
in
g 
IC
S
 
fo
r 
fir
st
 t
im
e 
or
 la
p
se
d
 u
se
rs
C
om
p
ar
at
or
: u
su
al
 c
ar
e.
Fo
llo
w
-u
p
 a
ss
es
sm
en
t:
 
18
 m
on
th
s
D
ur
at
io
n 
of
 t
he
 IV
R
 
in
te
rv
en
tio
n:
 U
nc
l
M
od
ifi
ca
tio
n 
of
 t
he
 
M
ed
ic
at
io
n 
P
os
se
ss
io
n 
R
at
io
, c
ol
le
ct
ed
 b
y 
el
ec
tr
on
ic
 m
ed
ic
al
 
re
co
rd
s.
Ta
b
le
 1
 
C
on
tin
ue
d
 
C
on
tin
ue
d
 o
n
 17 June 2019 by guest. Protected by copyright.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2017-018974 on 24 February 2018. Downloaded from 
9Tsoli S, et al. BMJ Open 2018;8:e018974. doi:10.1136/bmjopen-2017-018974
Open Access
(Hedges’ g=−0.077, 95% CI −0.162 to 0.007, k=4, p=0.073). 
No study reported statistically significant evidence in 
favour of the comparator condition compared to the IVR 
intervention (figure 2).
Studies targeting physical activity, alcohol and dietary 
behaviours were highly homogeneous (all had I²=0.00%), 
whereas studies targeting medication adherence were 
highly heterogeneous (I²=93.84%).
Analysis by study size
Subgroup analysis was conducted to examine any differ-
ences in the overall effect size due to differences in study 
sample size, and results showed no significant effects. 
Specifically, for diet interventions, the smaller size study 
had larger effect size (Hedges’ g=0.285, 95% CI −0.222 
to 0.792, k=1) in comparison with the larger size study 
(Hedges’ g=0.095, 95% CI −0.146 to 0.335, k=1); however, 
that difference was not significantly different. For physical 
activity interventions, studies of smaller size had a larger 
effect size (Hedges’ g=0.346, 95% CI 0.055 to 0.636, k=2) 
in comparison to the large size study (Hedges’ g=0.191, 
95% CI −0.051 to 0.432, k=1); however, that difference 
was not significantly different. For alcohol interventions, 
smaller size studies had a larger effect size (Hedges’ 
g=−0.058, 95% CI −0.150 to 0.034, k=2) in comparison 
to larger size studies (Hedges’ g=−0.181, 95% CI −0.395 
to 0.032, k=2); however, that difference was not signifi-
cantly different. For medication adherence interventions, 
studies of smaller size had a larger effect size (OR=1.86, 
95% CI 1.328 to 2.605, k=4) in comparison to studies 
of larger size (OR=1.35, 95% CI 1.009 to 1.820, k=6); 
however, that difference was not significantly different.
Publication bias
Inspection of the funnel plot appears to suggest asym-
metry in the plot, more pronounced in the larger studies 
(figure 3). However, Egger’s test for asymmetry was not 
statistically significant (p=0.534). Nevertheless, the pres-
ence of funnel plot asymmetry could have resulted from 
other reasons apart from publication bias,51 such as 
participants’ characteristics at baseline.
Meta-regression analyses
Due to the small number of studies on physical activity, 
alcohol and diet, it was not possible to explore what BCTs 
were associated with intervention effect sizes (online 
supplementary file 4).
Meta-regression analysis was performed only on the studies 
aiming to promote medication adherence. BCTs coded in 
at least three studies were included in the meta-regression 
analyses. Univariable meta-regression analysis of the medica-
tion adherence studies showed that the BCTs ‘personalised’ 
(τ²=0.028, R²=0.73, p=0.006), ‘social support (unspecified)’ 
(τ²=0.101, R²=0.03, p=0.043) and ‘information about health 
consequences’ (τ²=0.003, R²=0.97,p=0.000) were associated 
with larger effect sizes (online supplementary file 4). 
Multivariable meta-regression analysis showed that the 
presence or absence of the six BCTs coded in medication A
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adherence studies explained 100% of the variance in 
intervention effect size. Moreover, the goodness of fit 
model was not statistically significant (τ²=0.000, τ=0.000, 
I²=0.00%, Q=0.04, df=2, p=0.981), suggesting that the 
effect size does not vary across studies that used/did not 
use the same BCTs. The multivariable meta-regression 
model showed that the BCT ‘information about health 
consequences’ was positively associated with a larger 
intervention effect size, when the remaining five BCTs 
were controlled for (β=0.690, SE=0.199, 95% CI 0.29 to 
1.08, p=0.000). None of the other five BCTs were signifi-
cantly associated with intervention effectiveness (online 
supplementary file 4). 
dIsCussIOn
Principal findings
The results from this meta-analysis of 15 RCTs suggest 
that IVR-based interventions are efficacious in changing 
medication adherence and physical activity but not 
alcohol or dietary behaviours. No effect of study size on 
overall effect size was detected for any of the behaviours. 
Results from the univariable meta-regression in medi-
cation adherence interventions suggested that the 
BCTs ‘personalised’, ‘social support (unspecified)’ and 
‘information about health consequences’ were associ-
ated with a larger effect. However, only the BCT ‘infor-
mation about health consequences’ was significant in 
the multivariable meta-regression analysis. This finding 
suggests that IVR interventions that include information 
about the health consequences of (not) taking medica-
tions as prescribed, are personalised and provide social 
support could increase adherence to different types of 
medication. For the interventions targeting physical 
activity, the most frequently used BCTs were ‘tailored’ 
and ‘self-monitoring of behaviour’, although conclu-
sions about their impact on intervention effectiveness 
could not be drawn. Similarly, conclusions about the 
use of the most frequently used BCTs and their impact 
on the non-efficacious alcohol and diet interventions 
could not be made.
strength and limitations
Caution should be applied when interpreting the results 
of this review due to the low quality of the included 
studies. Despite this, studies of higher quality had posi-
tive effects on changing medication adherence and 
physical activity behaviours, and considering that these 
studies included objective outcome measurements or 
Table 2 Risk of bias of included studies by behaviour
Author, year
Random 
sequence 
generation
Allocation 
concealment
Blinding of participants, 
personnel and outcome 
assessors
Incomplete 
outcome 
data
Selective 
reporting
Objective 
outcome 
assessment
Other 
bias
Alcohol consumption
  Andersson,25 2015 ? ? − + + − ?
  Helzer et al,6 2008 ? ? − + − − ?
  Rose et al,39 2015 ? ? − ? ? − +
  Rose et al,43 2017 + ? + ? ? − +
Medication adherence
  Cizmic et al,31 2015 + ? − + ? + +
  Derose et al,32 2013 + ? − + ? + +
  Migneault et al,42 2012 + ? − ? ? − +
  Sherrard et al,38 2009 ? + − + − − +
  Sherrard et al,35 2015 + ? − − ? − +
  Shet et al,34 2014 ? + − + ? + +
  Stacy et al,36 2009 ? ? − + ? + +
  Vollmer et al,37 2011 ? ? − + ? + +
  Vollmer et al,33 2014 + ? − + ? + +
Diet
  Estabrooks,41 2008 ? ? − + ? − ?
  Migneault et al,42 2012 + ? − ? ? − +
Physical activity
  Estabrooks,41 2008 ? ? − + ? + ?
  King et al,40 2007 + ? − + ? − +
  Migneault et al,42 2012 + ? − ? ? − +
Note: ‘+’ indicates low risk of bias; ‘−’ indicates high risk of bias; ‘?’ indicates unclear risk of bias.
 o
n
 17 June 2019 by guest. Protected by copyright.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2017-018974 on 24 February 2018. Downloaded from 
11Tsoli S, et al. BMJ Open 2018;8:e018974. doi:10.1136/bmjopen-2017-018974
Open Access
their subjective measurements had been validated by 
objective measurements, such interventions could have 
a significant impact on public health if applied on a 
large scale.
However, seven eligible studies could not be included 
in the meta-analysis due to missing outcome data. Thus, 
the effects might have been slightly different from those 
estimated by the present analyses. Studies were excluded 
during full-text screening due to outcome measures not 
being comparable with the outcomes of interest. However, 
among the studies not included in the analysis, only one 
study47 did not confirm the benefits of IVR-based interven-
tions. Grey literature was not searched; thus it is possible 
that some studies were missed. The meta-regression findings 
Figure 2 Forest plots of the Hedges’ g (95% CI) for alcohol, diet and physical activity interventions and OR (95% CI) for the 
medication adherence interventions. Differences are presented between the intervention and a comparator condition. 
Figure 3 Funnel plot of precision against Hedges’ g. 
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also need to be interpreted with caution due to the small 
number of studies51 and the high correlation of the BCTs.
how this review is different from previous studies
To our knowledge, the current review is the first attempt 
to summarise the best available evidence on IVR-based 
interventions and investigate the intervention content 
that may be associated with their effectiveness; thus 
comparability with previous reviews is limited. The 
only comparable review is that by Posadzki et al15 which 
suggested that IVR interventions are probably effective 
in producing small effects on alcohol, diet, physical 
activity and medication adherence. However, due to the 
small number and high heterogeneity of the included 
studies, Posadzki et al did not conduct meta-regression 
analysis to identify the active components of the inter-
ventions for specific behaviours.
To achieve this, the present review included inter-
ventions that were comparable in terms of interven-
tion components, outcomes and outcome measures. 
The analysis of alcohol, diet and physical activity inter-
ventions showed that the effects were homogeneous 
(I²=0.00%). Moreover, the meta-regression analysis on 
medication adherence interventions explained 100% 
of the variance in intervention effect. These findings 
could inform the development of future IVR interven-
tions targeting changes in such health behaviours.
Possible mechanisms and implications for future research
The included IVR-delivered interventions varied in 
several elements of the delivery mode, which might 
have contributed to the estimated effects. For example, 
the degree of interaction with patients varied widely 
among the interventions. Some studies described a 
more interactive system that might have increased 
participants’ engagement with the intervention (eg, 
31 40). An interesting feature of some of the IVR inter-
ventions was the use of culturally sensitive voices (eg, 
25 42) or prerecorded messages of their therapist's voice 
to increase acceptability of the intervention.39 Further-
more, another study provided participants with the 
opportunity to choose the gender and language of the 
voice delivering the IVR intervention.34 These features 
of the delivery mode could have influenced engage-
ment with the intervention and potentially impacted on 
its effectiveness.
Providing information about the health conse-
quences appeared effective in promoting medication 
adherence. Such information usually includes the 
advantages of taking medications or the disadvan-
tages of not taking them. This finding is in line with a 
recent review that investigated the BCTs that promote 
adherence to cardiometabolic medications.14 However, 
it further suggests that such a technique might be 
effective in promoting adherence to different types of 
cardiometabolic medication and to medications for 
different health conditions (eg, oral bisphosphonate 
for osteoporosis, antiretroviral treatment for HIV and 
inhaled corticosteroids for asthma). Social support 
(unspecified) was associated with larger intervention 
effect size. This finding is in line with previous research 
that suggests that types of perceived social support are 
significantly associated with medication adherence.52 It 
is also possible that IVR voice messages might increase 
the sense of social support, in comparison to other 
delivery modes, due their resemblance to ‘natural’ 
verbal communication40 or due to the availability of the 
IVR for patients to call in and ask for support.
For alcohol, dietary and physical activity interventions, 
some of the coded BCTs have previously been associ-
ated with intervention effectiveness: ‘self-monitoring 
of behaviour’ and ‘action planning’ for both dietary 
and physical activity interventions53 and ‘feedback on 
behaviour’ for alcohol interventions.54 However, due 
to the limited number of included studies, it was not 
possible to draw conclusions about the efficacy of these 
BCTs to promote behaviour changes.
Moreover, the primary studies did not provide a 
detailed description of the content and delivery mode 
for the comparator condition, which limits our ability to 
interpret the effect of the successful interventions.55 A 
number of other factors need to be further investigated 
when interpreting the findings of this review, such as 
participants’ characteristics at baseline, the recruitment 
setting and the study design.
COnClusIOn
This review provides evidence about the effective-
ness of IVR interventions to promote specific health 
behaviours and therefore promote public health. It 
also provides evidence on the BCTs that are associated 
with the effectiveness of IVR interventions to support 
adherence to medication prescribed for different 
long-term health conditions. Considering the poten-
tial of the IVR to deliver effective interventions, and 
the evidence on its acceptability to facilitate behaviour 
change messages,8 interventions to promote changes to 
a single, or multiple, behaviours should be developed 
and evaluated. Moreover, future studies could usefully 
test the feasibility, effectiveness and cost-effectiveness of 
IVR-based interventions for different health behaviours, 
and in different settings, using rigorous designs and 
objective outcome measures.
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